News & Media

We invite you to follow our progress as we move forward in the completion and installation of our first high-efficiency,environmentally responsible urea manufacturing plants. Subscribe today to receive news, updates and investor alerts.

Press Releases

Plant Construction Updates

Sign Up for
Investor Alerts

press releases

BioNitrogen Engages Adam Friedman Associates as Investor Relations Counsel

  • Bion User
  • June. 21, 2012

MIAMI, FL, Jun 21, 2012 (MARKETWIRE via COMTEX) — BioNitrogen Corporation (PINKSHEETS: BION) today announced it has retained New York-based Adam Friedman Associates LLC as its investor relations counsel.
Mr. Carlos Contreras, President and CEO, commented, “We have engaged Adam Friedman Associates to assist us with our investor relations needs because of their strong reputation and proven track record of producing results for their clients.”

Commenting on the news, Adam Friedman, Principal, said, “BioNitrogen is strategically positioned to become a serious player in providing urea fertilizer for the global market. We look forward to working with the management of BioNitrogen to introduce them to investors who are interested in a company with strong potential.”

About BioNitrogen Corporation

BioNitrogen Corp. (PINKSHEETS: BION) is focused on building turnkey manufacturing facilities to produce urea, which is principally used in the agricultural industry as a crop fertilizer. Our innovative, patent-pending technologies transform residual agricultural waste and other biomass materials into high-quality bulk urea for sale to agricultural wholesalers and retailers. Additional information can be found at

About Adam Friedman Associates

Adam Friedman Associates is a leading independent investor relations firm headquartered in New York City, specializing in the strategic practice of corporate and investor relations. For more information visit the web site

Safe Harbor Statement

The forward-looking statements contained in this document involve risks and uncertainties that may affect the Company’s operations, markets, products, services, prices and other factors as discussed in filings with the Securities and Exchange Commission. These risks and uncertainties include, but are not limited to, economic, competitive, legal, governmental and technological factors. Accordingly, there is no assurance that the Company’s expectations will be realized. The Company assumes no obligation to provide revisions to any forward-looking statements should circumstances change, except as otherwise required by securities and other applicable laws.


Adam Friedman
Adam Friedman Associates
Email Contact:
Tel: 917-675-6250

SOURCE: BioNitrogen Corporation


2014 Investor Fact Sheet

Investor Alerts

Please provide us with your email address to receive investor alerts and other news.

Investor Relations Contact

Molly Nuland

Pentant LLC
(203) 553-9825

Select Language